Literature DB >> 17138047

The aetiology and pathogenesis of chronic allograft nephropathy.

P J Yates1, M L Nicholson.   

Abstract

Renal transplantation is the ultimate form of renal replacement therapy, and is the treatment of choice for many patients with end-stage renal failure. The advent of calcineurin inhibitor based immunosuppression resulted in the 1-year renal allograft failure rate dropping from around 50% twenty years ago to less than 10% in more recent times. Despite a massive improvement in renal allograft survival in the first year following transplantation 10-year graft survival can be as low as 50%. Chronic allograft nephropathy (CAN) is recognised as the main cause of renal allograft failure following the first year after transplantation. The diagnosis of CAN can only be made histologically. Typically biopsy specimens in grafts with CAN demonstrate an overall fibrotic appearance effecting the vascular endothelium, renal tubules, interstitium, and glomerulus. The risk factors for CAN are divided into alloimmune and alloimmune independent. Alloimmune dependent factors include acute cellular rejection, severity of rejection, subclinical rejection and HLA mismatch. Alloimmune independent factors such as delayed graft function, donor age, Cytomegalovirus infection, donor/recipient co-morbidity and of course calcineurin inhibitor toxicity are important in the development of CAN. The pathogenesis of CAN is complex, multifactorial, and unfortunately incompletely understood. There are a number of pivotal steps in the initiation and propagation of the fibrosis seen in biopsy specimens from kidneys with CAN. Endothelial activation in response to one or more of the aforementioned risk factors stimulates leukocyte activation and recruitment. Recruited leukocytes subsequently infiltrate through the endothelium and induce key effector cells to secrete excessive and abnormal extracellular matrix (ECM). Enhanced deposition of ECM is a histological hallmark of CAN. This paper aims to present a concise yet accurate and up-to-date review of the literature concerning the aetiological factors and pathological processes which are present in the generation of CAN.

Entities:  

Mesh:

Year:  2006        PMID: 17138047     DOI: 10.1016/j.trim.2006.10.001

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  18 in total

1.  Periodontitis case definition affects the association with renal function in kidney transplant recipients.

Authors:  E Ioannidou; M Shaqman; J Burleson; A Dongari-Bagtzoglou
Journal:  Oral Dis       Date:  2010-10       Impact factor: 3.511

2.  HDL Cholesterol Efflux Predicts Graft Failure in Renal Transplant Recipients.

Authors:  Wijtske Annema; Arne Dikkers; Jan Freark de Boer; Robin P F Dullaart; Jan-Stephan F Sanders; Stephan J L Bakker; Uwe J F Tietge
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

3.  Safety and efficacy of administering the maximal dose of candesartan in renal transplant recipients.

Authors:  Masayoshi Okumi; Noritaka Kawada; Naotsugu Ichimaru; Harumi Kitamura; Toyofumi Abe; Ryoichi Imamura; Yasuyuki Kojima; Yukito Kokado; Yoshitaka Isaka; Hiromi Rakugi; Norio Nonomura; Toshiki Moriyama; Shiro Takahara
Journal:  Clin Exp Nephrol       Date:  2011-08-05       Impact factor: 2.801

4.  Peroxisome proliferator-activated receptor (PPAR)gamma can inhibit chronic renal allograft damage.

Authors:  Eva Kiss; Zoran V Popovic; Jens Bedke; Judith Adams; Mahnaz Bonrouhi; Andrea Babelova; Claudia Schmidt; Frank Edenhofer; Inka Zschiedrich; Sophie Domhan; Amir Abdollahi; Liliana Schäfer; Norbert Gretz; Stefan Porubsky; Hermann-Josef Gröne
Journal:  Am J Pathol       Date:  2010-04-02       Impact factor: 4.307

5.  Suppression of chronic damage in renal allografts by Liver X receptor (LXR) activation relevant contribution of macrophage LXRα.

Authors:  Eva Kiss; Zoran Popovic; Jens Bedke; Shijun Wang; Mahnaz Bonrouhi; Norbert Gretz; Paula Stettner; Daniel Teupser; Joachim Thiery; Stefan Porubsky; Judith Adams; Hermann-Josef Gröne
Journal:  Am J Pathol       Date:  2011-05-05       Impact factor: 4.307

6.  Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood.

Authors:  Sunil M Kurian; Raymond Heilman; Tony S Mondala; Aleksey Nakorchevsky; Johannes A Hewel; Daniel Campbell; Elizabeth H Robison; Lin Wang; Wen Lin; Lillian Gaber; Kim Solez; Hamid Shidban; Robert Mendez; Randolph L Schaffer; Jonathan S Fisher; Stuart M Flechner; Steve R Head; Steve Horvath; John R Yates; Christopher L Marsh; Daniel R Salomon
Journal:  PLoS One       Date:  2009-07-10       Impact factor: 3.240

7.  Mycophenolic acid inhibits oleic acid-induced mesangial cell activation through both cellular reactive oxygen species and inosine monophosphate dehydrogenase 2 pathways.

Authors:  Kyu Ha Huh; Hyung Joon Ahn; Jehyun Park; Man Ki Ju; Jae Sook Song; Myoung Soo Kim; Soon Il Kim; Yu Seun Kim
Journal:  Pediatr Nephrol       Date:  2008-12-18       Impact factor: 3.714

8.  The impact of acute rejection in kidney transplantation on long-term allograft and patient outcome.

Authors:  Mojgan Jalalzadeh; Nouraddin Mousavinasab; Said Peyrovi; Mohammad Hassan Ghadiani
Journal:  Nephrourol Mon       Date:  2015-01-20

9.  Genomic meta-analysis of growth factor and integrin pathways in chronic kidney transplant injury.

Authors:  Amrita Dosanjh; Elizabeth Robison; Tony Mondala; Steven R Head; Daniel R Salomon; Sunil M Kurian
Journal:  BMC Genomics       Date:  2013-04-23       Impact factor: 3.969

10.  Therapeutic Drug Monitoring, Electronic Health Records, and Pharmacokinetic Modeling to Evaluate Sirolimus Drug Exposure-Response Relationships in Renal Transplant Patients.

Authors:  Kanecia O Zimmerman; Huali Wu; Rachel Greenberg; Jeffrey T Guptill; Kevin Hill; Uptal D Patel; Lawrence Ku; Daniel Gonzalez; Christoph Hornik; Wenlei Jiang; Nan Zheng; Chiara Melloni; Michael Cohen-Wolkowiez
Journal:  Ther Drug Monit       Date:  2016-10       Impact factor: 3.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.